Literature DB >> 23722869

Endoscopic evaluation of gastrointestinal tract in patients with hereditary hemorrhagic telangiectasia and correlation with their genotypes.

Cecilia Canzonieri1, Laura Centenara2, Federica Ornati1, Fabio Pagella3, Elina Matti3, Costanza Alvisi2, Cesare Danesino1, Maurizio Perego2, Carla Olivieri1.   

Abstract

PURPOSE: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal-dominant vascular dysplasia characterized by telangiectases and arteriovenous malformations. Three causative genes are known: ENG (HHT-1), ACVRL1 (HHT-2), and SMAD4 (mutated in HHT in association with juvenile polyposis). Gastrointestinal bleeding is the most common symptom after epistaxis. The stomach and the duodenum are the main gastrointestinal sites of telangiectases. Our aim was to explore gastrointestinal tract of consecutive HHT patients to assess distribution, number, size, and type of telangiectases in relation to genotype.
METHODS: HHT patients underwent gastroduodenoscopy, video capsule endoscopy, and colonoscopy. Molecular analysis of ENG and ACVRL1 was performed to identify the disease-causing mutation.
RESULTS: Twenty-two patients (13 men; mean age: 59 ± 9 years) were analyzed: 7 with HHT-1, 13 with HHT-2, and 2 undefined. Gastrointestinal telangiectases were identified as follows: at gastroduodenoscopy in 86% of HHT-1 patients and in 77% of HHT-2 patients, at video capsule endoscopy in all HHT-1 patients and in 84% of HHT-2 patients, and at colonoscopy in 1 patient for each group. HHT-1 showed multiple telangiectases with a higher prevalence, more relevant in the duodenum.
CONCLUSION: Our data demonstrate extensive involvement of the gastrointestinal tract with a more severe association in HHT-1. Gastroduodenoscopy provides significant information on gastrointestinal involvement, and video capsule endoscopy may be added in selected patients. Colonic polyps/adenomas were identified as occasional findings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23722869     DOI: 10.1038/gim.2013.62

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  19 in total

Review 1.  Colorectal cancer risk in hamartomatous polyposis syndromes.

Authors:  Fábio Guilherme Campos; Marleny Novaes Figueiredo; Carlos Augusto Real Martinez
Journal:  World J Gastrointest Surg       Date:  2015-03-27

Review 2.  Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature.

Authors:  Samuel B Jackson; Nicholas P Villano; Jihane N Benhammou; Michael Lewis; Joseph R Pisegna; David Padua
Journal:  Dig Dis Sci       Date:  2017-08-23       Impact factor: 3.199

3.  Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management.

Authors:  Adrienne M Hammill; Katie Wusik; Raj S Kasthuri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 4.  Optimal management of hereditary hemorrhagic telangiectasia.

Authors:  Neetika Garg; Monica Khunger; Arjun Gupta; Nilay Kumar
Journal:  J Blood Med       Date:  2014-10-15

Review 5.  Rendu-Osler-Weber disease: a gastroenterologist's perspective.

Authors:  Annalisa Tortora; Maria Elena Riccioni; Eleonora Gaetani; Veronica Ojetti; Grainne Holleran; Antonio Gasbarrini
Journal:  Orphanet J Rare Dis       Date:  2019-06-07       Impact factor: 4.123

6.  PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1.

Authors:  Adriana Iriarte; Agnes Figueras; Pau Cerdà; José María Mora; Anna Jucglà; Rosa Penín; Francesc Viñals; Antoni Riera-Mestre
Journal:  Cells       Date:  2019-08-24       Impact factor: 6.600

7.  Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.

Authors:  Yong Hwan Kim; Phuong-Nhung Vu; Se-Woon Choe; Chang-Jin Jeon; Helen M Arthur; Calvin P H Vary; Young Jae Lee; S Paul Oh
Journal:  Circ Res       Date:  2020-07-31       Impact factor: 17.367

8.  Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.

Authors:  Muaaz Masood; Michael Coles; Humberto Sifuentes
Journal:  Case Rep Gastrointest Med       Date:  2021-06-29

9.  The Impact of Small Bowel Endoscopy in Patients with Hereditary Hemorrhagic Telangiectasia

Authors:  Stefania Chetcuti Zammit; David S. Sanders; Mark E. McAlindon; Reena Sidhu
Journal:  Turk J Haematol       Date:  2018-07-24       Impact factor: 1.831

10.  Diagnostic yield of capsule endoscopy for small bowel arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.

Authors:  Kevin Singh; Ayla Zubair; Andrew Prindle; Ahmed Jamal Nadeem; Gulam Khan
Journal:  Endosc Int Open       Date:  2019-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.